Long-Term Effects of Severe COVID-19 on Lung Function and Immune Health
Author Information
Author(s): Strumiliene Edita, Urbonienė Jurgita, Jurgauskiene Laimute, Zeleckiene Ingrida, Bliudzius Rytis, Malinauskiene Laura, Zablockiene Birutė, Samuilis Arturas, Jancoriene Ligita
Primary Institution: Vilnius University
Hypothesis
What are the long-term pulmonary and immunological effects in patients recovering from severe COVID-19 pneumonia?
Conclusion
Survivors of severe COVID-19 pneumonia experience significant long-term impairments in lung function and immune system health.
Supporting Evidence
- Pulmonary function tests showed significant improvement over time.
- Residual inflammatory changes on CT decreased from 77.63% at 6 months to 69.62% at 12 months.
- CD8+ T cell levels were linked to improved pulmonary outcomes.
- Patients with higher CD4+ T cell counts had worse lung function.
- Regular monitoring of lung function and immune parameters is essential for post-COVID care.
Takeaway
People who had severe COVID-19 might still have trouble breathing and their immune system might not work as well even after a year.
Methodology
This was a prospective observational cohort study that followed 85 adult patients for 12 months after severe COVID-19 pneumonia, assessing lung function and immune parameters.
Potential Biases
The lack of a control group for mild or moderate COVID-19 cases may confound the interpretation of long-term effects.
Limitations
The study had a small sample size and was conducted at a single center, which may limit the generalizability of the findings.
Participant Demographics
The median age of participants was 59 years, with 47.1% women and 52.9% men.
Statistical Information
P-Value
p < 0.001
Confidence Interval
95% CI 0.98–1.00
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website